209 related articles for article (PubMed ID: 12580958)
21. Resistance of leukemic blasts to lymphokine activated killer (LAK)-mediated cytotoxicity is not related to their adhesion properties.
Palucka AK; Porwit A; Reizenstein P
Eur J Haematol; 1991 Aug; 47(2):123-7. PubMed ID: 1716215
[TBL] [Abstract][Full Text] [Related]
22. Increased expression of costimulatory molecules on peripheral blood monocytes in patients with Crohn's disease.
Liu ZX; Hiwatashi N; Noguchi M; Toyota T
Scand J Gastroenterol; 1997 Dec; 32(12):1241-6. PubMed ID: 9438323
[TBL] [Abstract][Full Text] [Related]
23. Up-regulation of costimulatory/adhesion molecules by histone deacetylase inhibitors in acute myeloid leukemia cells.
Maeda T; Towatari M; Kosugi H; Saito H
Blood; 2000 Dec; 96(12):3847-56. PubMed ID: 11090069
[TBL] [Abstract][Full Text] [Related]
24. Efficient generation of antileukemic autologous T cells by short-term culture and gamma-irradiation of myeloid leukemic cells.
Vereecque R; Saudemont A; Depil S; Corm S; Andrieux J; Soenen-Cornu V; Quesnel B
Cancer Immunol Immunother; 2004 Sep; 53(9):793-8. PubMed ID: 15098140
[TBL] [Abstract][Full Text] [Related]
25. Monocytes in children with leukemias and lymphomas -- down-regulation of HLA and costimulatory molecules.
Łuczyński W; Stasiak-Barmuta A; Krawczuk-Rybak M; Szymański M; Malinowska I; Mitura-Lesiuk M
Acta Biochim Pol; 2004; 51(4):1067-73. PubMed ID: 15625579
[TBL] [Abstract][Full Text] [Related]
26. CD80 and CD86 C domains play an important role in receptor binding and co-stimulatory properties.
Vasu C; Wang A; Gorla SR; Kaithamana S; Prabhakar BS; Holterman MJ
Int Immunol; 2003 Feb; 15(2):167-75. PubMed ID: 12578846
[TBL] [Abstract][Full Text] [Related]
27. Costimulatory molecules CD80 and CD86 in human crescentic glomerulonephritis.
Wu Q; Jinde K; Endoh M; Sakai H
Am J Kidney Dis; 2003 May; 41(5):950-61. PubMed ID: 12722029
[TBL] [Abstract][Full Text] [Related]
28. The expression of LFA-1, ICAM-1, CD80 and CD86 molecules in lupus patients: implication for immunotherapy.
Takasaki Y; Abe K; Tokano Y; Hashimoto H
Intern Med; 1999 Feb; 38(2):175-7. PubMed ID: 10225679
[No Abstract] [Full Text] [Related]
29. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
[TBL] [Abstract][Full Text] [Related]
30. Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells.
Moosig F; Csernok E; Wang G; Gross WL
Clin Exp Immunol; 1998 Oct; 114(1):113-8. PubMed ID: 9764612
[TBL] [Abstract][Full Text] [Related]
31. Certain HLA antigens are associated with specific morphologic and cytogenetic subsets of acute myeloid leukemia.
Joventino LP; Stock W; Lane NJ; Daly KM; Mick R; Le Beau MM; Larson RA
Leukemia; 1995 Mar; 9(3):433-9. PubMed ID: 7885042
[TBL] [Abstract][Full Text] [Related]
32. Flow cytometric investigation of immune-response-related surface molecules on human colorectal cancers.
Diederichsen AC; Stenholm AC; Kronborg O; Fenger C; Jensenius JC; Zeuthen J; Christensen PB; Kristensen T
Int J Cancer; 1998 Jun; 79(3):283-7. PubMed ID: 9645352
[TBL] [Abstract][Full Text] [Related]
33. Alloreaction increases or restores CD40, CD54, and/or HLA molecule expression in acute myelogenous leukemia blasts, through secretion of inflammatory cytokines: Dominant role for TNFbeta, in concert with IFNgamma.
Eljaafari A; Van Snick J; Voisin A; Cormont F; Farre A; Bienvenu J; Bernaud J; Rigal D; Thomas X
Leukemia; 2006 Nov; 20(11):1992-2001. PubMed ID: 16990783
[TBL] [Abstract][Full Text] [Related]
34. CD40 activation of carcinoma cells increases expression of adhesion and major histocompatibility molecules but fails to induce either CD80/CD86 expression or T cell alloreactivity.
Vonderheide RH; Butler MO; Liu JF; Battle TE; Hirano N; Gribben JG; Frank DA; Schultze JL; Nadler LM
Int J Oncol; 2001 Oct; 19(4):791-8. PubMed ID: 11562757
[TBL] [Abstract][Full Text] [Related]
35. Dendritic cells generated from acute myeloid leukemia (AML) blasts maintain the expression of immunogenic leukemia associated antigens.
Li L; Reinhardt P; Schmitt A; Barth TF; Greiner J; Ringhoffer M; Döhner H; Wiesneth M; Schmitt M
Cancer Immunol Immunother; 2005 Jul; 54(7):685-93. PubMed ID: 15627212
[TBL] [Abstract][Full Text] [Related]
36. Rapid generation of antigen-presenting cells from leukaemic blasts in acute myeloid leukaemia.
Westers TM; Stam AG; Scheper RJ; Regelink JC; Nieuwint AW; Schuurhuis GJ; van de Loosdrecht AA; Ossenkoppele GJ
Cancer Immunol Immunother; 2003 Jan; 52(1):17-27. PubMed ID: 12536236
[TBL] [Abstract][Full Text] [Related]
37. Treatment of cutaneous T cell lymphoma with extracorporeal photopheresis induces Fas-ligand expression on treated T cells, but does not suppress the expression of co-stimulatory molecules on monocytes.
Bladon J; Taylor PC
J Photochem Photobiol B; 2003 Feb; 69(2):129-38. PubMed ID: 12633985
[TBL] [Abstract][Full Text] [Related]
38. Acute myelogenous leukemia blasts as accessory cells during in vitro T lymphocyte activation.
Bruserud O; Ulvestad E
Cell Immunol; 2000 Nov; 206(1):36-50. PubMed ID: 11161436
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the skin sensitization potential of chemicals using expression of co-stimulatory molecules, CD54 and CD86, on the naive THP-1 cell line.
Yoshida Y; Sakaguchi H; Ito Y; Okuda M; Suzuki H
Toxicol In Vitro; 2003 Apr; 17(2):221-8. PubMed ID: 12650676
[TBL] [Abstract][Full Text] [Related]
40. Human acute lymphoblastic leukemia (ALL) blasts as accessory cells during T-cell activation: differences between patients in costimulatory capacity affect proliferative responsiveness and cytokine release by activated T cells.
Bruserud O; Ulvestad E
Cancer Immunol Immunother; 2003 Apr; 52(4):215-25. PubMed ID: 12669246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
